New insights into the responder/nonresponder divide in rectal cancer: Damage-induced Type I IFNs dictate treatment efficacy and can be targeted to enhance radiotherapy.
Uccello TP, Lesch ML, Kintzel SA, Gradzewicz LB, Lamrous L, Murphy SP, Fleming FJ, Mills BN, Murphy JD, Hughson A, Hannon G, Garrett-Larsen J, Qiu H, Drage MG, Ye J, Gavras NW, Keeley DC, Love TMT, Repasky EA, Lord EM, Linehan DC, Gerber SA.
Uccello TP, et al. Among authors: fleming fj.
Cell Death Dis. 2023 Jul 26;14(7):470. doi: 10.1038/s41419-023-05999-3.
Cell Death Dis. 2023.
PMID: 37495596
Free PMC article.